3.0.0 8905 2023-01-11T13:44:01Z 2023-01-11T13:44:01Z House HR 2020-12-08 116 [Congressional Record Volume 166, Number 207 (Tuesday, December 8, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. VAN DREW:H.R. 8905.Congress has the power to enact this legislation pursuantto the following:The Congress shall have power to lay and collect taxes,duties, imposts and excises, to pay the debts and provide forthe common defense and general welfare of the United States;but all duties, imposts and excises shall be uniformthroughout the United States;[Page H7046]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2020-12-08T15:01:45Z 2020-12-08 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-12-08 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-12-08 Introduced in House IntroReferral 1000 9 Library of Congress V000133 Rep. Van Drew, Jefferson [R-NJ-2] Jefferson Van Drew R NJ 2 N Health Drug safety, medical device, and laboratory regulation Manufacturing Health 00 2020-12-08 Introduced in House 2021-02-19T16:33:12Z Supply Chain Security and Pharmaceutical Authentication Act of 2020

This bill modifies the application of requirements for drug packaging to include certain information, such as the product's lot number and expiration date.

Under the bill, the requirements shall apply to the packaging of the smallest or individual solid oral dosage form of the product. Currently, such requirements apply to the smallest container (which might contain multiple dosages) of the product that is intended for individual sale to a dispenser, such as a pharmacy.

]]> Supply Chain Security and Pharmaceutical Authentication Act of 2020 Display Title Supply Chain Security and Pharmaceutical Authentication Act of 2020 Short Title(s) as Introduced Supply Chain Security and Pharmaceutical Authentication Act of 2020 Introduced in House IH Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat of counterfeit drugs to the pharmaceutical supply chain, and to make the pharmaceutical supply chain more robust, while ensuring the authenticity, content, purity, and manufacturing location and batch number of drugs (including COVID-19 therapeutics and vaccines) and allowing patient verification of authenticity, and for other purposes. Introduced in House IH Introduced in House 2020-12-08T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr8905ih/xml/BILLS-116hr8905ih.xml 2020-12-08 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.